Voltaren Schmerzgel forte

Voltaren is a widely recognized pharmaceutical brand specializing in topical and oral pain relief treatments. The brand was originally developed in Switzerland by Ciba-Geigy, which later became part of Novartis. Today, Voltaren is a flagship brand in the consumer healthcare market, known for its primary active ingredient, Diclofenac, which serves as a non-steroidal anti-inflammatory drug (NSAID) to treat joint and muscle pain.

Ownership of the Voltaren brand has evolved through major corporate shifts. While Novartis remains a key player in the brand's history, the consumer healthcare division was transitioned into a joint venture with GSK, eventually leading to the spin-off of Haleon in 2022. As of now, Haleon, a global leader in consumer health headquartered in the United Kingdom, is the ultimate owner and distributor of Voltaren products globally.

Manufacturing of Voltaren products occurs in multiple high-tech pharmaceutical facilities across Europe and North America to meet international demand. The German packaging shown indicates its distribution in Central European markets, often supplied by regional manufacturing hubs in Switzerland or Germany.